Breaking
Friday, June 19, 2026

FDA News

🇺🇸 FDA Page 20

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 229–240 of 391 articles

Medium impact NewsMay 29, 2026

Experimental IgG4-RD Drug Submission to FDA After Successful Trial

FDA · IgG4-RD · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 29, 2026

FDA PreCheck Pilot Program Launches: A New Era for Clinical Trials

FDA · 4 min

Dr. Sarah Mitchell
Medium impact NewsMay 29, 2026

FDA Loosens Regulations on Digital Health Tools

FDA · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 29, 2026

US FDA Extends Decision Date for Camizestrant Filing

FDA · oncology · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 28, 2026

FDA Delays Decision on AstraZeneca Breast Cancer Pill: What It Means

FDA · breast cancer · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 28, 2026

Lifesaving Upgrades: 40 Years of FDA Oncology Approvals

FDA · oncology · 3 min

Dr. Sarah Mitchell
Medium impact NewsMay 28, 2026

FDA Guidelines Enhance Generic Bioequivalence in Oncology Drugs

FDA · oncology · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 28, 2026

FDA Calendar 2026: Key Approval Dates and PDUFA Insights

FDA · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 28, 2026

FDA Restricts Large-Scale Compounding of Weight Loss Drugs

FDA · weight loss · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 28, 2026

FDA Clarifies 3-Year Exclusivity Guidance: Key Insights

FDA · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 28, 2026

Industry Groups Push for FDA Guidance Changes on Form 483 Responses

FDA · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 27, 2026

Potential FDA Approval for Eye Drug: What It Means for Pharma

FDA · 3 min

Dr. Sarah Mitchell